Bruce Neal

147.7k total citations · 24 hit papers
517 papers, 38.1k citations indexed

About

Bruce Neal is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bruce Neal has authored 517 papers receiving a total of 38.1k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Public Health, Environmental and Occupational Health, 168 papers in Endocrinology, Diabetes and Metabolism and 146 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bruce Neal's work include Nutritional Studies and Diet (142 papers), Sodium Intake and Health (128 papers) and Diabetes Treatment and Management (114 papers). Bruce Neal is often cited by papers focused on Nutritional Studies and Diet (142 papers), Sodium Intake and Health (128 papers) and Diabetes Treatment and Management (114 papers). Bruce Neal collaborates with scholars based in Australia, United Kingdom and United States. Bruce Neal's co-authors include Vlado Perkovic, Kenneth W. Mahaffey, Mark Woodward, John Chalmers, Dick de Zeeuw, David R. Matthews, Greg Fulcher, Wayne Shaw, Mehul Desai and Stephen MacMahon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Bruce Neal

503 papers receiving 36.8k citations

Hit Papers

Canagliflozin and Cardiov... 2001 2026 2009 2017 2017 2015 2010 2013 2009 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    2017 5.4k citations Bruce Neal, Vlado Perkovic et al. profile →
  2. Worldwide access to treatment for end-stage kidney disease: a systematic review
    2015 1.5k citations Bruce Neal, Anthony Rodgers et al. profile →
  3. Severe Hypoglycemia and Risks of Vascular Events and Death
    2010 1.1k citations Sophia Zoungas, Anushka Patel et al. profile →
  4. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
    2013 1.1k citations Bruce Neal et al. profile →
  5. Intensive glucose control and macrovascular outcomes in type 2 diabetes
    2009 829 citations John Chalmers, Bruce Neal et al. profile →
  6. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
    2009 692 citations Vlado Perkovic, Sophia Zoungas et al. profile →
  7. The global burden of diabetes and its complications: an emerging pandemic
    2010 675 citations Bruce Neal et al. profile →
  8. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
    2010 656 citations Min Jun, Bruce Neal et al. profile →
  9. A Systematic Review of the Impact of Adherence on the Effectiveness of e-Therapies
    2011 636 citations Bruce Neal et al. profile →
  10. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
    2015 619 citations Bruce Neal, Mark Woodward et al. profile →
  11. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    2019 600 citations Brendon L. Neuen, Hiddo J.L. Heerspink et al. profile →
  12. Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
    2012 560 citations Bruce Neal, Mark Woodward et al. PLoS Medicine profile →
  13. Blood Pressure Lowering Treatment Trialists’ Collaboration
    2001 526 citations Bruce Neal profile →
  14. Blood Pressure Lowering in Type 2 Diabetes
    2015 510 citations Kazem Rahimi, Bruce Neal et al. profile →
  15. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
    2008 504 citations Craig S. Anderson, Hisatomi Arima et al. profile →
  16. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
    2018 468 citations Vlado Perkovic, Dick de Zeeuw et al. profile →
  17. INFORMAS (International Network for Food and Obesity/non‐communicable diseases Research, Monitoring and Action Support): overview and key principles
    2013 444 citations Boyd Swinburn, Stefanie Vandevijvere et al. Obesity Reviews profile →
  18. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
    2016 379 citations Jason Wu, Vlado Perkovic et al. profile →
  19. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
    2017 375 citations Kenneth W. Mahaffey, Bruce Neal et al. Circulation profile →
  20. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus
    2018 368 citations Karin Rådholm, Vlado Perkovic et al. Circulation profile →
  21. Salt Reduction Initiatives around the World – A Systematic Review of Progress towards the Global Target
    2015 327 citations Kathy Trieu, Bruce Neal et al. profile →
  22. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials
    2020 251 citations Liping Huang, Kathy Trieu et al. BMJ profile →
  23. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis
    2019 227 citations Brendon L. Neuen, Min Jun et al. profile →
  24. Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
    2023 132 citations Brendon L. Neuen, Hiddo J.L. Heerspink et al. Circulation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bruce Neal 16.0k 9.3k 7.5k 7.0k 5.3k 517 38.1k
Jiang He 10.7k 0.7× 19.7k 2.1× 10.8k 1.4× 5.8k 0.8× 5.6k 1.1× 668 55.4k
Paul Muntner 8.1k 0.5× 23.1k 2.5× 6.6k 0.9× 7.4k 1.1× 2.7k 0.5× 730 50.8k
James B. Meigs 15.0k 0.9× 9.4k 1.0× 8.5k 1.1× 5.3k 0.8× 5.5k 1.0× 400 44.5k
Earl S. Ford 15.7k 1.0× 9.8k 1.1× 13.3k 1.8× 5.6k 0.8× 4.0k 0.8× 349 54.1k
Barbara V. Howard 15.6k 1.0× 11.9k 1.3× 8.6k 1.1× 7.1k 1.0× 5.7k 1.1× 559 45.1k
Kay‐Tee Khaw 9.4k 0.6× 6.6k 0.7× 8.9k 1.2× 6.0k 0.9× 4.6k 0.9× 617 41.4k
Nancy R. Cook 6.8k 0.4× 14.3k 1.5× 9.0k 1.2× 8.8k 1.3× 4.7k 0.9× 440 51.2k
Paul K. Whelton 9.7k 0.6× 24.6k 2.7× 11.8k 1.6× 4.3k 0.6× 3.0k 0.6× 418 48.6k
Elizabeth Selvin 12.1k 0.8× 8.0k 0.9× 2.3k 0.3× 5.5k 0.8× 4.1k 0.8× 518 33.1k
Hertzel C. Gerstein 26.6k 1.7× 12.3k 1.3× 2.9k 0.4× 8.1k 1.2× 8.8k 1.7× 505 51.2k

Countries citing papers authored by Bruce Neal

Since Specialization
Citations

This map shows the geographic impact of Bruce Neal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Neal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Neal more than expected).

Fields of papers citing papers by Bruce Neal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Neal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Neal. The network helps show where Bruce Neal may publish in the future.

Co-authorship network of co-authors of Bruce Neal

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Neal. A scholar is included among the top collaborators of Bruce Neal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Neal. Bruce Neal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatur, Safia, Muthiah Vaduganathan, Robert A. Fletcher, et al.. (2025). Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-Level Pooled Analysis of the CANVAS and CREDENCE Trials. European Journal of Heart Failure. 27(6). 994–1002. 1 indexed citations
2.
Barraclough, Jennifer, Ziba Gandomkar, Robert A. Fletcher, et al.. (2025). Predicting cardiovascular events from routine mammograms using machine learning. Heart. 112(5). 261–269. 1 indexed citations
3.
Eyles, Helen, Yannan Jiang, Rachael McLean, et al.. (2023). Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial. JMIR mhealth and uhealth. 11. e43675–e43675. 10 indexed citations
4.
Trieu, Kathy, Daisy H. Coyle, Emalie Rosewarne, et al.. (2023). Estimated Dietary and Health Impact of the World Health Organization’s Global Sodium Benchmarks on Packaged Foods in Australia: a Modeling Study. Hypertension. 80(3). 541–549. 12 indexed citations
5.
Yin, Xuejun, Anthony Rodgers, Liping Huang, et al.. (2022). Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart. 108(20). 1608–1615. 34 indexed citations
6.
7.
Marklund, Matti, Gitanjali Singh, Raquel C. Greer, et al.. (2020). Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study. BMJ. 369. m824–m824. 62 indexed citations
8.
Shahid, Maria, Bruce Neal, & Alexandra Jones. (2020). Uptake of Australia’s Health Star Rating System 2014–2019. Nutrients. 12(6). 1791–1791. 46 indexed citations
9.
Oshima, Megumi, Meg Jardine, Rajiv Agarwal, et al.. (2020). Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney International. 99(4). 999–1009. 114 indexed citations
10.
Dunford, Elizabeth, Cliona Ní Mhurchú, Liping Huang, et al.. (2019). A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 2013–2018. Obesity Reviews. 20(S2). 107–115. 43 indexed citations
11.
12.
Jones, Alexandra, Karin Rådholm, & Bruce Neal. (2018). Defining ‘Unhealthy’: A Systematic Analysis of Alignment between the Australian Dietary Guidelines and the Health Star Rating System. Nutrients. 10(4). 501–501. 38 indexed citations
13.
Karmali, Kunal N., Donald M. Lloyd‐Jones, Joep van der Leeuw, et al.. (2018). Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLoS Medicine. 15(3). e1002538–e1002538. 67 indexed citations
14.
Jones, Alexandra, Maria Shahid, & Bruce Neal. (2018). Uptake of Australia’s Health Star Rating System. Nutrients. 10(8). 997–997. 46 indexed citations
15.
Mahaffey, Kenneth W., Bruce Neal, Vlado Perkovic, et al.. (2017). Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events. Circulation. 137(4). 323–334. 375 indexed citations breakdown →
16.
Peters, Sanne A. E., Elizabeth Dunford, Lisa J. Ware, et al.. (2017). The Sodium Content of Processed Foods in South Africa during the Introduction of Mandatory Sodium Limits. Nutrients. 9(4). 404–404. 54 indexed citations
17.
Hata, Jun, Hisatomi Arima, Peter M. Rothwell, et al.. (2013). Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Circulation. 128(12). 1325–1334. 163 indexed citations
18.
Jeffery, Patricia, Lynn Riddell, Jonathan E Shaw, et al.. (2013). CORRELATION BETWEEN 24-HOUR AND SPOT/VOID URINE SAMPLES FOR THE PURPOSE OF POPULATION SALT INTAKE ASSESSMENT. Deakin Research Online (Deakin University). 1 indexed citations
19.
20.
Neal, Bruce, Anthony Rodgers, Taane G. Clark, et al.. (2000). No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients. Acta Orthopaedica Scandinavica. 71(2). 129–134. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang He Breakdown of academic impact, for papers by Paul Muntner Breakdown of academic impact, for papers by James B. Meigs Breakdown of academic impact, for papers by Earl S. Ford Breakdown of academic impact, for papers by Barbara V. Howard Breakdown of academic impact, for papers by Kay‐Tee Khaw Breakdown of academic impact, for papers by Nancy R. Cook Breakdown of academic impact, for papers by Paul K. Whelton Breakdown of academic impact, for papers by Elizabeth Selvin Breakdown of academic impact, for papers by Hertzel C. Gerstein
Rankless by CCL
2026